Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events.

Chen SY, Wu N, Gulseth M, LaMori J, Bookhart BK, Boulanger L, Fields L, Schein J.

J Manag Care Pharm. 2013 May;19(4):291-301.

2.

Treatment of DVT: how long is enough and how do you predict recurrence.

Agnelli G, Becattini C.

J Thromb Thrombolysis. 2008 Feb;25(1):37-44. Review.

PMID:
17906973
3.

Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.

Marik PE, Cavallazzi R.

PLoS One. 2015 Nov 20;10(11):e0143252. doi: 10.1371/journal.pone.0143252. Review.

4.

Venous thromboembolism in cancer patients.

Deng A, Galanis T, Graham MG.

Hosp Pract (1995). 2014 Dec;42(5):24-33. doi: 10.3810/hp.2014.12.1156. Review.

PMID:
25485915
5.

Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.

Douketis J, Tosetto A, Marcucci M, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Iorio A.

Ann Intern Med. 2010 Oct 19;153(8):523-31. doi: 10.7326/0003-4819-153-8-201010190-00009. Review.

PMID:
20956709
6.

Long-term anticoagulation for venous thromboembolism: duration of treatment and management of warfarin therapy.

Kearon C.

Clin Chest Med. 2010 Dec;31(4):719-30. doi: 10.1016/j.ccm.2010.06.003. Review.

PMID:
21047578
7.

Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation.

Ensor J, Riley RD, Jowett S, Monahan M, Snell KIe, Bayliss S, Moore D, Fitzmaurice D; PIT-STOP collaborative group..

Health Technol Assess. 2016 Feb;20(12):i-xxxiii, 1-190. doi: 10.3310/hta20120. Review.

8.

Aspirin and recurrent venous thromboembolism.

Prandoni P, Noventa F, Milan M.

Phlebology. 2013 Mar;28 Suppl 1:99-104. doi: 10.1177/0268355512475040. Review.

PMID:
23482543
9.

Venous thromboembolism: Predicting recurrence and the need for extended anticoagulation.

Barnes GD, Kanthi Y, Froehlich JB.

Vasc Med. 2015 Apr;20(2):143-52. doi: 10.1177/1358863X14566429. Review.

10.

[D-dimers measurement to predict the risk of thromboembolic recurrence].

Righini M, Perrier A.

Rev Med Interne. 2008 Jun;29(6):476-81. doi: 10.1016/j.revmed.2007.12.012. Review. French.

PMID:
18255199
11.

Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. A meta-analysis.

Chai-Adisaksopha C, Hillis C, Monreal M, Witt DM, Crowther M.

Thromb Haemost. 2015 Oct;114(4):819-25. doi: 10.1160/TH15-01-0063. Review.

PMID:
26018236
12.

Risk assessment for recurrence and optimal agents for extended treatment of venous thromboembolism.

Agnelli G, Becattini C.

Hematology Am Soc Hematol Educ Program. 2013;2013:471-7. doi: 10.1182/asheducation-2013.1.471. Review.

PMID:
24319221
13.

Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis.

Douketis J, Tosetto A, Marcucci M, Baglin T, Cosmi B, Cushman M, Kyrle P, Poli D, Tait RC, Iorio A.

BMJ. 2011 Feb 24;342:d813. doi: 10.1136/bmj.d813. Review.

14.

Real-World Medical Cost Avoidance When New Oral Anticoagulants are Used Versus Warfarin for Venous Thromboembolism in the United States.

Amin A, Bruno A, Trocio J, Lin J, Lingohr-Smith M.

Clin Appl Thromb Hemost. 2016 Jan;22(1):5-11. doi: 10.1177/1076029615585991. Review.

PMID:
25993994
15.

Assessing the risk of recurrent venous thromboembolism--a practical approach.

Fahrni J, Husmann M, Gretener SB, Keo HH.

Vasc Health Risk Manag. 2015 Aug 17;11:451-9. doi: 10.2147/VHRM.S83718. Review.

16.

Predicting the risk of venous thromboembolism recurrence.

Heit JA.

Am J Hematol. 2012 May;87 Suppl 1:S63-7. doi: 10.1002/ajh.23128. Review.

17.

Limited evidence on persistence with anticoagulants, and its effect on the risk of recurrence of venous thromboembolism: a systematic review of observational studies.

Vora P, Soriano-GabarrĂ³ M, Suzart K, Persson Brobert G.

Patient Prefer Adherence. 2016 Aug 29;10:1657-65. doi: 10.2147/PPA.S112297. Review.

18.

Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism.

Witt DM, Clark NP, Kaatz S, Schnurr T, Ansell JE.

J Thromb Thrombolysis. 2016 Jan;41(1):187-205. doi: 10.1007/s11239-015-1319-y. Review.

19.

Language, Literacy, and Communication Regarding Medication in an Anticoagulation Clinic: Are Pictures Better Than Words?.

Schillinger D, Machtinger EL, Wang F, Chen LL, Win K, Palacios J, Rodriguez M, Bindman A.

In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb.

20.

Preventing Medication Errors in Ambulatory Care: The Importance of Establishing Regimen Concordance.

Schillinger D, Machtinger E, Wang F, Rodriguez M, Bindman A.

In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in Patient Safety: From Research to Implementation (Volume 1: Research Findings). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb.

Items per page

Supplemental Content

Support Center